Economic Evaluation of Outpatients with Type 2 Diabetes Mellitus Assisted by a Pharmaceutical Care Service
Overview
Authors
Affiliations
Objective: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service.
Subjects And Methods: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist.
Results: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits.
Conclusion: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.
Torres L, Azevedo P, Rocha Sarmento T, Ramalho-de-Oliveira D, Reis E, Godoi I J Comp Eff Res. 2024; 13(4):e230127.
PMID: 38329429 PMC: 11044949. DOI: 10.57264/cer-2023-0127.
Goncalves A, Cazarim M, Sanches C, Pereira L, Camargos A, Aquino J BMJ Open Diabetes Res Care. 2019; 7(1):e000647.
PMID: 31413839 PMC: 6673768. DOI: 10.1136/bmjdrc-2018-000647.
The costs of diabetes treatment in low- and middle-income countries: a systematic review.
Moucheraud C, Lenz C, Latkovic M, Wirtz V BMJ Glob Health. 2019; 4(1):e001258.
PMID: 30899566 PMC: 6407562. DOI: 10.1136/bmjgh-2018-001258.
Cazarim M, Pereira L PLoS One. 2018; 13(3):e0193567.
PMID: 29509802 PMC: 5839560. DOI: 10.1371/journal.pone.0193567.
Hospital pharmacy workforce in Brazil.
Santos T, Penm J, Baldoni A, Ayres L, Moles R, Sanches C Hum Resour Health. 2018; 16(1):1.
PMID: 29301559 PMC: 5755413. DOI: 10.1186/s12960-017-0265-5.